688189 南新制药
2024/03 -
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资0--0000
投资性房地产0--0000
固定资产181,423-1.88%184,895200,731223,585226,720
在建工程5730.00%5732401,275516
无形资产140,56213.10%124,284138,006158,41365,569
商誉10,8450.00%10,84510,84513,56928,256
其他非流动资产116,282-8.39%126,928108,614120,84651,814
449,6850.48%447,525458,436517,689372,875

流动资产
货币资金644,597-3.18%665,761713,472730,668299,351
应收账款522,625-3.92%543,962728,193590,813639,973
存货31,39910.50%28,41627,01561,42553,337
其他流动资产46,992-9.41%51,87227,492230,275720,483
1,245,613-3.44%1,290,0111,496,1721,613,1811,713,144

流动负债
短期借款285,158-11.70%322,950488,733385,437235,249
应付票据0--0080,0000
应付帐款46,90918.61%39,54837,49676,46720,208
其他流动负债58,603-12.46%66,944122,127132,766126,141
390,670-9.03%429,442648,355674,671381,598
流动资产净值854,944-0.65%860,569847,817938,5101,331,546
资产总额减流动负债1,304,628-0.27%1,308,0951,306,2531,456,1991,704,421

非流动负债
长期借款0--0050,84676,260
应付债券0--0000
其他非流动负债5,622-2.53%5,7689,88111,3709,010
5,622-2.53%5,7689,88162,21685,270

总权益
    实收股本274,4000.00%274,400196,000140,000140,000
    储备项目1,039,485-0.41%1,043,7161,118,3651,253,1971,455,818
股东权益1,313,885-0.32%1,318,1161,314,3651,393,1971,595,818
非控股权益(14,879)-5.77%(15,790)(17,993)78623,333